Skip to main content

Table 1 Baseline demographics and clinical characteristics of the RA patients included in the study

From: Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis

  RA patients (n = 23)
Demographics
 Age, years 52.6 (2.8)*
 Gender, % female 77
Clinical characteristics  
 Disease duration, years 4.7 (1)
 Rheumatoid factor and/or anti-CCP positive, % 30
 Disease activity score in 28 joints 6 (0.2)
 Swollen (28) 8.7 (1.2)
 Tender (28) 10.8 (1.7)
 C-reactive protein, mg/dL 2.4 (1.3)
 Erythrocyte sedimentation rate, mm/h 39.8 (7.3)
Treatments
 Naïve to treatment, n/total (%) 13/23 (56 %)
 Methotrexate, n/total (%) 7/23 (30)
 Methotrexate dose, mg/week 17.1 (1.5)
 Leflunomide, n/total (%) 3/23 (13)
 Biologic agents, n/total (%) 4/23 (17)
 Glucocorticoids, n/total (%) 5/23 (22)
 Glucocorticoid dose, mg/day 8.2 (3.3)
  1. *Except where indicated otherwise, values are the mean (standard error of the mean). anti-CCP anti-cyclic citrullinated peptide